Healthcare -
Biotechnology - NASDAQ - US
$ 1.93
2.12 %
$ 78.9 M
Market Cap
-0.93
P/E
Price Target
Average
469.95%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
31.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vigil Neuroscience, Inc.
Wall Street analysts predict an average 1-year price target for VIGL of $11 , with forecasts ranging from
a
low of
$11 to a high of $11 .
VIGL Lowest Price Target
Wall Street Target
11 USD
469.95%
VIGL Average Price Target
Wall Street Target
11 USD
469.95%
VIGL Highest Price Target
Wall Street Target
11 USD
469.95%
REVENUE FORECAST
Revenue Forecast Chart VIGL
EBIT FORECAST
EBIT Forecast Chart VIGL
NET INCOME FORECAST
Net Income Chart VIGL